PODDS&P 500

Insulet Corporation SEC filings, summarized

We read every Insulet Corporation 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.

Track PODD in your inbox

Add Insulet Corporation to your watchlist — free, every morning.

Subscribe free

Recent filings

8-KMarch 12, 2026

Insulet ($PODD) filed a Form 8‑K on Mar 12, 2026 furnishing a press release (Exhibit 99.1) dated Mar 12, 2026.

Insulet ($PODD) filed a Form 8‑K on Mar 12, 2026 furnishing a press release (Exhibit 99.1) dated Mar 12, 2026. No other substantive Item disclosures in Item…

8-KMarch 12, 2026

Mar 12, 2026: Insulet ($PODD) says voluntary medical-device correction; expects up to $40M of costs, all…

Mar 12, 2026: Insulet ($PODD) says voluntary medical-device correction; expects up to $40M of costs, all in 2026. Costs will be excluded from adjusted…

8-KMarch 4, 2026

Insulet ($PODD) on Feb 27, 2026 entered a severance agreement with former CFO Ana M.

Insulet ($PODD) on Feb 27, 2026 entered a severance agreement with former CFO Ana M. Chadwick. It implements previously disclosed severance/post‑termination…

8-KFebruary 18, 2026

Insulet ($PODD) filed an 8‑K on Feb 18, 2026 furnishing a press release as Exhibit 99.1.

Insulet ($PODD) filed an 8‑K on Feb 18, 2026 furnishing a press release as Exhibit 99.1. Filing signed by CFO Flavia H. Pease. Review the press release for…

8-KFebruary 18, 2026

On Feb 13, 2026 Insulet's Board approved a $350M increase to the prior $125M share repurchase…

On Feb 13, 2026 Insulet's Board approved a $350M increase to the prior $125M share repurchase authorization, extending the program through 12/31/2027 —…

8-KFebruary 18, 2026

Insulet ($PODD) announced Q4 & full-year 2025 financial results on Feb 18, 2026 covering the period ended…

Insulet ($PODD) announced Q4 & full-year 2025 financial results on Feb 18, 2026 covering the period ended Dec 31, 2025. Press release is furnished as…

8-KFebruary 3, 2026

Insulet filed an Addendum (Exhibit 10.1) effective Jan 1, 2026 to its Purchase Agreement with NXP USA, Inc.

Insulet filed an Addendum (Exhibit 10.1) effective Jan 1, 2026 to its Purchase Agreement with NXP USA, Inc. (original agreement Oct 12, 2017). Certain…

8-KFebruary 3, 2026

BREAKING: Insulet ($PODD) confirms addendum with NXP ($NXPI) extending their Purchase Agreement effective…

BREAKING: Insulet ($PODD) confirms addendum with NXP ($NXPI) extending their Purchase Agreement effective Jan 1, 2026 — pricing, product volumes & order…

8-KDecember 19, 2025

Insulet ($PODD) filed an 8‑K (Item 9.01) on Dec 19, 2025 — furnished Exhibit 16.1: letter from Grant…

Insulet ($PODD) filed an 8‑K (Item 9.01) on Dec 19, 2025 — furnished Exhibit 16.1: letter from Grant Thornton LLP to the SEC (dated Dec 19, 2025) and…

8-KDecember 19, 2025

On Dec 15, 2025 Insulet’s Audit Committee approved appointment of PwC as its independent auditor (subject…

On Dec 15, 2025 Insulet’s Audit Committee approved appointment of PwC as its independent auditor (subject to standard client acceptance) and dismissed Grant…

8-KDecember 19, 2025

Insulet filed an 8‑K on 12/19/2025 — Item 9.01 exhibits: Ex.16.1 = letter from Grant Thornton LLP to the…

Insulet filed an 8‑K on 12/19/2025 — Item 9.01 exhibits: Ex.16.1 = letter from Grant Thornton LLP to the SEC (dated 12/19/2025); Ex.104 = Inline XBRL cover…

8-KDecember 19, 2025

Dec 15, 2025 — Insulet's Audit Committee approved appointment of PwC as its independent registered public…

Dec 15, 2025 — Insulet's Audit Committee approved appointment of PwC as its independent registered public accounting firm (subject to standard client…